Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.
about
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsImmunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusAdvanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.Development of capture assays for different modifications of human low-density lipoprotein.Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men.Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateDetection of IgE, IgG, IgA and IgM antibodies against raw and processed food antigens.Mangosteen pericarp extract inhibits the formation of pentosidine and ameliorates skin elasticityAdvanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Lipoprotein autoantibodies: measurement and significance.Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetesPentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthaseAdvanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.Galectin-3 expression in human atherosclerotic lesions.Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patientsGlycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesisHigh levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor.Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits.Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEsIncreased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers.Advanced glycation endproducts in neurofilament conglomeration of motoneurons in familial and sporadic amyotrophic lateral sclerosis.Plasma Levels of Advanced Glycation End Products Are Related to the Clinical Presentation and Angiographic Severity of Symptomatic Lower Extremity Peripheral Arterial Disease.Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.Use of human vascular tissue microarrays for measurement of advanced glycation endproductsIncreased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix.Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanismsThe impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diaInfluence of insulin and muscle fiber type in nepsilon-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus.Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosisRole of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipidemia and hyperglycemia, a process attenuated by L-arginine.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.
P2860
Q24530074-F88AFA86-D6F7-4BB5-B533-C9B868A38F91Q24561776-62B9556F-3749-48C3-8EB6-171AC97D738DQ26829529-13E12245-65B9-4A6C-ADD5-50AC9E75D748Q33563689-9AF1AED2-2E3A-42B6-B904-7CAE37F49F93Q33593614-4A805934-A0B3-4AFE-85B4-83FC046DF3CBQ34185801-08BD0280-4D54-496C-8A48-98C281680872Q34286094-776AA60A-02BF-416F-9254-3869A14DCBC3Q34607563-C6E8BB59-6C47-48A3-A9CA-83358132C9DEQ34672018-DBA15434-4D4C-4547-8A71-9AF14D3EABDBQ34981419-CDF0DE52-02E4-4AF3-B66B-6CD1F31A3777Q35140009-9E49BFBE-A45C-4D05-97C0-83111F73E8F6Q35140825-33EE22EE-2EB0-4521-9448-C2F60A5615F3Q35544336-17E69BFA-533C-46A9-AAEC-18C67AF6A9E2Q35753534-53341B46-062A-4595-A1A8-64363C81383AQ35764706-75A2961E-16B0-40CD-A949-9FE24CB6A156Q35765442-94CBD1DD-B36F-4B9E-85E2-5C04396A2AA8Q35800420-DC4B4AD6-7829-4311-AA6B-E87E0E4A81A9Q36052417-A8E7EB45-48BB-421D-AE58-F5097D241BAFQ36318280-5340CD42-C6C5-4446-A597-63ACEAA71DABQ36320445-A460E7D7-69E5-4878-82DF-07BB9B585173Q36426832-B551CE21-F613-4293-B88C-A08D0D11FFF7Q36437599-FA037FB5-BD81-4529-8C56-40ED88A4CBF3Q36437790-0486AD53-47CB-4359-A4F8-99EFC6FB2B57Q36438245-9BE2F1A3-06CB-4536-82CD-98BD0EA3D0F0Q36438378-2A5DFD39-0D84-426A-97BE-275098FCE879Q36593852-FA16CF76-9AB2-4B3C-B3E1-E9DA47DA2182Q37184929-A03B0494-9764-4B92-9B88-EC2151F6609BQ37212344-13D16578-3AD0-4AD4-9B89-88FDC8B9F091Q37363088-8F20B72C-AE0E-4C57-A1EA-6B79F7900AF0Q37371152-984A741C-06DD-48CC-B90B-09E00E95D416Q37404625-1F9A14BF-BB1C-45FA-A8BE-02A33E570756Q37636453-2BA9205B-4274-4CA7-88D8-5C9F15C368CFQ37660885-D3C1A7CE-5B1E-4EA2-9BF6-190DB5605655Q38292287-832B531C-235D-40C5-AC60-E4AFF6308B94Q39107928-8F6988AD-652B-4B44-998E-A0905BA3175AQ39598754-83AC7FE0-D075-4100-9022-2C0AA4658A77Q40547285-4FF4A5D3-5897-4C65-AA21-9CC4BEE4F98AQ42724707-6F969960-8FD1-453F-B8A3-E0876892D284Q45072634-74F092F6-893C-4630-B16A-AF270B21C94EQ51636281-E44D13BF-9550-4455-A6F0-CB8E28811B34
P2860
Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@ast
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@en
type
label
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@ast
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@en
prefLabel
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@ast
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@en
P2093
P2860
P1476
Immunohistochemical localizati ...... c tissue in diabetes mellitus.
@en
P2093
H Vlassara
T Kagoshima
Y Nakamura
Y Sakaguchi
P2860
P304
P407
P577
1993-12-01T00:00:00Z